Conference Coverage

Late risks of breast cancer RT are higher for smokers


 

AT SABCS 2015

References

Numbers of heart disease events were sufficient to establish a linear relationship, according to Dr. Taylor. Numbers of lung cancers were not, but case-control studies in the literature with adequate numbers have identified a linear relationship there, too. “We use what we can, and we have got now several hundred events, if you combine all of the literature together. And they do suggest the dose-response relationship is linear, but we can’t know that for certain,” she said.

Pages

Recommended Reading

Cancer incidence higher in men, blacks
MDedge ObGyn
Neratinib shows consistent breast cancer benefit at 3 years
MDedge ObGyn
ESR1 mutations linked with poorer survival from ER-positive breast cancer
MDedge ObGyn
T-DM1 trial points way to de-escalation of breast cancer therapy
MDedge ObGyn
Ovarian suppression during breast cancer chemotherapy helped preserve long-term function
MDedge ObGyn
VIDEO: Dr. William Gradishar says tools to define patients for targeted therapy are on the horizon
MDedge ObGyn
VIDEO: Dr. Hope S. Rugo discusses immunotherapy, neoadjuvant treatment highlights
MDedge ObGyn
Can aspirin prevent breast cancer?
MDedge ObGyn
‘Fear and ignorance’ drive rise in bilateral mastectomy
MDedge ObGyn
Pembrolizumab shows promise in PD-L1–positive breast cancer
MDedge ObGyn